Antipsychotic drugs opposite to metabolic risk: neurotransmitters, neurohormonal and pharmacogenetic mechanisms underlying with weight gain and metabolic syndrome
about
Antipsychotic drugs opposite to metabolic risk: neurotransmitters, neurohormonal and pharmacogenetic mechanisms underlying with weight gain and metabolic syndrome
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antipsychotic drugs opposite t ...... ht gain and metabolic syndrome
@en
Antipsychotic drugs opposite t ...... t gain and metabolic syndrome.
@nl
type
label
Antipsychotic drugs opposite t ...... ht gain and metabolic syndrome
@en
Antipsychotic drugs opposite t ...... t gain and metabolic syndrome.
@nl
prefLabel
Antipsychotic drugs opposite t ...... ht gain and metabolic syndrome
@en
Antipsychotic drugs opposite t ...... t gain and metabolic syndrome.
@nl
P2093
P2860
P921
P1476
Antipsychotic drugs opposite t ...... ht gain and metabolic syndrome
@en
P2093
Anna Capasso
Luca Milano
Michele De Rosa
Walter Milano
P2860
P356
10.2174/1874205X01307010023
P577
2013-05-31T00:00:00Z